CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: We investigated the transcriptome profiles and the consequent deregulation of genes and pathways in CD34+/lin- cells from 78 CP-CML patients at diagnosis vs. 12 months of nilotinib treatment by microarray analysis.